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acerebellarl organ requires the establishment of its proper size as well as the establishment
of the relative proportions of its individual components. In the zebraﬁsh heart, organ size and proportion
depend heavily on the number of cells in each of its two major chambers, the ventricle and the atrium. Heart
size and chamber proportionality are both affected in zebraﬁsh fgf8 mutants. To determine when and how
FGF signaling inﬂuences these characteristics, we examined the effect of temporally controlled pathway
inhibition. During cardiac speciﬁcation, reduction of FGF signaling inhibits formation of both ventricular and
atrial cardiomyocytes, with a stronger impact on ventricular cells. After cardiomyocyte differentiation begins,
reduction of FGF signaling can still result in a deﬁciency of ventricular cardiomyocytes. Consistent with two
temporally distinct roles for FGF, we ﬁnd that increased FGF signaling induces a cardiomyocyte surplus only
before cardiac differentiation begins. Thus, FGF signaling ﬁrst regulates heart size and chamber
proportionality during cardiac speciﬁcation and later reﬁnes ventricular proportion by regulating cell
number after the onset of differentiation. Together, our data demonstrate that a single signaling pathway can
act reiteratively to coordinate organ size and proportion.
© 2008 Elsevier Inc. All rights reserved.IntroductionOrgan size is highly consistent among individuals of the same
species. Similarly, the distinct subunits of an organ typically develop
with the same relative proportions in each individual (Cook and Tyers,
2007; Hidalgo and ffrench-Constant, 2003). Comparison between
different species suggests that organ size and proportion are highly
dependent on cell number, although cell size can also inﬂuence organ
dimensions (Auman and Yelon, 2004; Hidalgo and ffrench-Constant,
2003; Nijhout, 2003; Potter and Xu, 2001; Raff, 1996; Trumpp et al.,
2001). Since organ size and proportion are critical for normal organ
function, it is important to elucidate the mechanisms that regulate
these parameters.
In the heart, each chamber serves as a distinct functional subunit,
and it has long been recognized that the relative proportions of the
cardiac chambers are constant under normal physiological conditions.
All normal adult human hearts have essentially the same number of
myocardial nuclei (Linzbach, 1960), suggesting that the cell number in
each chamber does not vary either. However, little is known about
how heart size and relative chamber proportion are coordinated
during embryonic development. Speciﬁcally, it is unclear when these).
l rights reserved.characteristics are acquired and if they are established simultaneously
or separately during development. It also remains unknown whether
heart size and chamber proportionality are established by the same
signaling pathways or require different sets of signals.
Fibroblast growth factors (FGFs) are appealing candidates for
signals that regulate the establishment of cardiomyocyte number.
FGFs comprise a large family of secreted polypeptides thought to
signal in a dose-dependent manner through receptor tyrosine kinases
(Böttcher and Niehrs, 2005). Studies in a number of model organisms
have implicated FGF signaling in cardiac speciﬁcation (Zaffran and
Frasch, 2002). In Drosophila, heartless (Fgfr) mutants completely lack
the dorsal vessel (Beiman et al., 1996); this phenotype reﬂects roles of
Fgfr both in mesoderm migration and in cardiac fate assignment
(Michelson et al., 1998). FGF signaling is also required to establish
cardiac identity in Ciona, and activation of FGF transcriptional targets
causes the transformation of anterior tail muscle cells into heart cells
(Davidson et al., 2006). In chick, FGF8 from the anterior endoderm
seems to contribute to its ability to induce the expression of cardiac
genes such as NKX2-5 andMEF2c (Alsan and Schultheiss, 2002; Zhu et
al., 1999). Fgf8 is also required to initiate nkx2.5 expression in
zebraﬁsh (Reifers et al., 2000): acerebellar (ace, fgf8) mutants exhibit
weak nkx2.5 expression at early stages, although expression recovers
as development proceeds. Inmouse, it has been difﬁcult to address the
role of FGF signaling in cardiac speciﬁcation, since Fgf8−/− (Sun et al.,
398 S.R. Marques et al. / Developmental Biology 321 (2008) 397–4061999) and Fgfr1−/− (Deng et al., 1994) mutant mice fail to complete
gastrulation. However, consistent with the roles of FGFs in other
species, in vitro studies have shown that Fgfr1−/− embryoid bodies fail
to express cardiac genes and do not form contractile foci (Dell'Era et
al., 2003).
FGFs may also contribute to the establishment of chamber
proportion. Prior studies have pointed out that loss of FGF signaling
causes more prominent defects in ventricles than it does in atria. In
zebraﬁsh, fgf8 mutants exhibit small hearts with particularly notable
reductions of the ventricle (Reifers et al., 2000). Additionally, mouse
embryos hypomorphic for Fgf8 (compound heterozygous Fgf8neo/−)
display a hypoplastic right ventricle and outﬂow tract along with a
complex series of other cardiovascular abnormalities (Abu-Issa et al.,
2002), as do tissue-speciﬁc knockout mice in which Fgf8 is deleted
from the anterior heart ﬁeld, a territory giving rise to the ventricles
and outﬂow tract (Ilagan et al., 2006; Park et al., 2006). Consistent
with a differential effect of FGF signaling on ventricular and atrial cells,
application of exogenous FGF2 or FGF4 in chick embryos promotes
ventricular myosin heavy chain 1 (VMHC1) gene expression and
decreases atrial myosin heavy chain (AMHC1) expression (Lopez-
Sanchez et al., 2002). It is not yet clear whether this series of
observations reﬂects a role of FGF signaling in setting the proper ratio
of ventricular and atrial cell numbers.
Here, we test the hypothesis that FGF signaling inﬂuences both
heart size and chamber proportionality through the establishment of
the proper numbers of cardiomyocytes. Using the zebraﬁsh heart as a
model, we systematically evaluate the impact of FGF signaling on the
number of ventricular and atrial cardiomyocytes by comparing the
roles of FGF at early stages, during cardiac speciﬁcation, and at later
stages, following myocardial differentiation. We ﬁnd that inhibition of
FGF signaling during cardiac speciﬁcation reduces the numbers of
both types of cardiomyocytes, with the ventricular lineage exhibiting
greater sensitivity over a longer period of time. Even after myocardial
differentiation is underway, FGF inhibition remains able to affect the
number of ventricular cardiomyocytes. Furthermore, we ﬁnd that
increased FGF signaling can induce excessive cardiomyocyte forma-
tion, but only prior to myocardial differentiation. Taken together, our
results indicate that FGF signaling has reiterative roles in regulating
heart size and chamber proportionality: early in development, FGF
signaling helps to establish properly sized and proportioned cardiac
progenitor pools, and, at later stages, FGF signaling continues to
contribute to the regulation of ventricular cell number, potentially by
controlling population maintenance or growth.
Materials and methods
Zebraﬁsh
Zebraﬁsh and embryos were maintained at 28.5 °C in standard
laboratory conditions. In addition towild-type ﬁsh, we used carriers of
the aceti282a mutation (Reifers et al., 1998), carriers of the transgene Tg
(cmlc2:DsRed2-nucf2) (Mably et al., 2003), and carriers of the transgene
Tg(hsp70:ca-fgfr1pd3). The Tg(hsp70:ca-fgfr1) construct allows heat
shock-inducible expression of a constitutively active form of Xenopus
Fgfr1. A point mutation in the Fgfr1 kinase domain (K562E) results in
autophosphorylation of the receptor in the absence of bound ligand
(Neilson and Friesel, 1996). A transgenic line was generated by
injecting 40 ng/mL of linearized, puriﬁed construct into zebraﬁsh
embryos at the 1-cell stage (Higashijima et al., 1997). We raised 200
injected embryos, screened the resulting ﬁsh for germline integration
of the transgene, and established lines from successful founders. The
Tg(hsp70:ca-fgfr1) construct also contains a cassette in which a 0.8 kb
dsred coding sequence (plus SV40 polyA; BD Biosciences) is driven by
the 0.7 kb zebraﬁsh α-crystallin promoter (Kurita et al., 2003); this
generates strong red ﬂuorescence in the lens that is recognizable by
48 h post-fertilization (hpf) and persists throughout adulthood,thereby facilitating identiﬁcation of transgenic ﬁsh in the F1 and
subsequent generations.
Immunoﬂuorescence and cell counting
To count cardiomyocytes in embryos carrying the transgene Tg
(cmlc2:DsRed2-nuc), we used immunoﬂuorescence to detect DsRed in
cardiomyocyte nuclei and atrial myosin heavy chain (Amhc) in atrial
cells, as described previously (Schoenebeck et al., 2007). Embryos
were compressed under a cover slip and photographed with a Zeiss
Axiocam on Zeiss M2Bio and Axioplan microscopes. Zeiss AxioVision
3.0.6 software and Adobe Photoshop Creative Suite were used to
process images before counting ﬂuorescent nuclei in each chamber.
When comparing sets of cell number data, Student's t-test (homo-
cedastic, two-tail distribution) was used to determine if the
differences between the means of data sets were statistically
signiﬁcant.
In situ hybridization
Anti-sense amhc, vmhc, cmlc2, pea3 and tbx5 probes were used for
in situ hybridization as previously described (Berdougo et al., 2003;
Brown et al., 1998; Yelon et al., 1999, 2000). Embryos were examined
on a Zeiss Axioplan microscope and photographed with a Zeiss
Axiocam. Zeiss AxioVision 3.0.6 software and Adobe Photoshop
Creative Suite were used to process images. Areas of gene expression
were measured using Image J (http://rsb.info.nih.gov/ij/index.html).
When comparing expression area data, Student's t-test (homocedas-
tic, two-tail distribution) was used to determine if the differences
between the means of data sets were statistically signiﬁcant.
SU5402 treatments
A 1 mM stock of SU5402 (Calbiochem) in DMSO was diluted to a
working concentration of 12.5 μM in E3 medium (Nusslein-Volhard
and Dahm, 2002), a concentration of SU5402 that causes a strong
reduction but does not completely abolish FGF signaling. Additional
experiments utilized a working concentration of 9 μM SU5402, a
concentration sufﬁcient to induce circulation defects and pericardial
edema. Up to 10 embryos were treated for discrete periods of time in
glass vials in a ﬁnal volume of 1 mL. Vials were kept in a nutator in the
dark at 28.5 °C. After treatment, embryos were washed in 50 mL of E3
medium and placed in new glass vials with fresh E3 medium. Control
embryos were treated with a corresponding dilution of DMSO in E3
medium.
In order to address the effectiveness of SU5402, we analyzed the
expression of the Fgf signaling pathway target gene polyoma enhancer
activator 3 (pea3), which is known to be abolishedwith higher doses of
SU5402 (Roehl and Nüsslein-Volhard, 2001). The concentration of
SU5402 used in our experiments strongly reduces pea3 expression as
soon as 30 min after exposure, and pea3 expression is restored 2 h
after SU5402 removal (SRM and DY, unpublished data). The length of
this recovery period is similar to that previously reported for SU5402
by others (Crump et al., 2004; Maroon et al., 2002; Nechiporuk et al.,
2005).
Heat shock conditions
Embryos from outcrosses of ﬁsh heterozygous for Tg(hsp70:ca-
fgfr1) were kept at 28.5 °C and heat shocked at desired stages.
Embryos were placed in 40 mL of embryo medium in a Petri dish on
top of a covered heat block for 20 min at 37 °C. Following heat shock,
transgenic embryos were identiﬁed by their elongated body mor-
phology at the 19-somite or 21-somite stages or by the expression of
the α-crystallin:dsred cassette in the lens at 48 hpf. Heat shocked non-
transgenic sibling embryos served as controls.
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acerebellar mutants have small hearts with disproportionately reduced
ventricles
Prior studies have shown that the zebraﬁsh mutation acerebellar
(aceti282a), a loss-of-function allele of fgf8, causes formation of
undersized hearts with a particular reduction of the ventricle (Reifers
et al., 1998, 2000). Wild-type hearts display characteristically curved
and expanded chambers (Fig. 1A), whereas ace mutant hearts
resemble immature, linear tubes (Fig. 1B). Cardiomyocyte cell shape
abnormalities contribute to the dysmorphic nature of the ace mutant
heart (SRM and DY, unpublished data): in particular, ventricular
cardiomyocytes in ace mutants do not undergo the regionalized
processes of cellular enlargement and elongation that usually
accompany chamber emergence (Auman et al., 2007). Since normal
chamber emergence requires blood ﬂow (Auman et al., 2007), this
phenotype is consistent with the failure of ace mutants to establish
circulation (Reifers et al., 2000). However, it is unclear whether the
chamber morphology defects in ace mutants simply reﬂect errors in
morphogenesis or may also be due to anomalies in cell number.
To determine whether the small dimensions of ace mutant hearts
are related to reduced cell numbers, we counted ventricular and atrial
cardiomyocytes in wild-type and ace mutant embryos. At 48 h post-
fertilization (hpf), wild-type hearts typically contain approximately
30% more ventricular cells than atrial cells (Fig. 1C; Supplemental
Table 1). In ace mutant hearts, total cell number is signiﬁcantly
reduced (Fig. 1C; Supplemental Table 1). Both ventricular and atrialFig. 1. ace mutant embryos have reduced numbers of both ventricular and atrial
cardiomyocytes. (A, B) Frontal views of hearts from wild-type (A) and ace mutant (B)
embryos at 48 hpf; immunoﬂuorescence detects DsRed (red) in all cardiomyocyte
nuclei and atrial myosin heavy chain (Amhc; green) in atrial cells. (A) In a wild-type
heart, the ventricle (red) and atrium (green) exhibit typical looping and expansion. (B)
In an ace mutant heart, the chambers are unlooped and small, with a particularly
apparent reduction of the ventricle. Scale bar represents 50 μm; both images are shown
at the same magniﬁcation. (C) Quantiﬁcation of cardiomyocytes at 48 hpf reveals that
the numbers of both ventricular and atrial cells are signiﬁcantly decreased in ace
mutants, with ventricular cell number being more affected then atrial cell number.
Graph indicates mean and standard deviation for each data set; asterisks indicate
statistically signiﬁcant differences relative to wild-type (pb0.005, Student's t-test).
n=13 for wild-type, and n=19 for ace mutants; see also Supplemental Table 1.
Fig. 2. Chamber disproportionality is evident prior to heart tube assembly in ace
mutants. (A–D) In situ hybridization depicts expression of vmhc (A, B) and amhc (C, D)
at the 21-somite stage; dorsal views, anterior to the top. Scale bar represents 50 μm; all
images are shown at the same magniﬁcation. (A) In wild-type embryos, vmhc is
expressed in a ring of ventricular cardiomyocytes just prior to heart tube extension. (B)
In ace mutant embryos, the population of vmhc-expressing cells is clearly reduced
(n=14/15). (C) amhc is expressed in a ring of atrial cardiomyocytes, surrounding the
ventricular cardiomyocytes. (D) The population of amhc-expressing cells is also reduced
in ace mutant embryos (n=11/13). (E) Graph indicates mean and standard deviation of
areas of expression (in μm2) of amhc and vmhc in wild-type and ace mutant embryos.
Asterisks indicate statistically signiﬁcant differences relative to wild-type (pb0.005,
Student's t-test). n≥10 for all data sets; see also Supplemental Table 2. (F) Graph
indicates fold difference in mean areas of gene expression relative to wild-type.cardiomyocyte populations are affected, but the ventricular cell loss is
more dramatic than the atrial cell loss (Fig. 1C; Supplemental Table 1).
As a result, ace mutant hearts typically contain approximately 50%
more atrial cells than ventricular cells (Fig. 1C; Supplemental Table 1).
Thus, in ace mutants, cell number deﬁciencies underlie abnormalities
in both organ size and chamber proportionality.
Chamber disproportionality is evident prior to heart tube assembly in
ace mutants
The overall reduction in cardiomyocyte number observed in ace
mutants is likely to reﬂect early defects in cardiac speciﬁcation, since
expression of several pre-cardiac markers fails to initiate properly in
the ace mutant lateral plate mesoderm (LPM) (Reifers et al., 2000).
However, these data do not resolve whether Fgf8 affects ventricular
and atrial lineages simultaneously. To evaluate ventricular and atrial
cardiomyocyte populations in the LPM, we examined expression of
the earliest known chamber-speciﬁc genes ventricular myosin heavy
chain (vmhc) and atrial myosin heavy chain (amhc) at the 21-somite
stage. At this timepoint, the two bilateral cardiac ﬁelds have migrated
toward the midline where they fuse to form a ring of cardiomyocytes
(Berdougo et al., 2003; Yelon et al., 1999). Even at this early stage, it is
clear that ace mutants exhibit diminished populations of both
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quantiﬁcation of the areas of vmhc and amhc expression reveals that
the effects on the ventricular population are more striking than the
effects on the atrial population (Figs. 2E, F; Supplemental Table 2).
Since the size and organization of individual vmhc-expressing andFig. 3. Transient reduction of FGF signaling leads to differential reduction of cardiomyocyte nu
addition and removal of SU5402. Black lines represent time intervals with normal FGF signali
only with DMSO, “continuous” SU5402 treatment extended from 30% epiboly (3 hpf) until
(10 hpf), “somitogenesis” treatment began at the 8-somite stage (13 hpf) and ended at 24 h
embryos, lateral views, exhibiting morphology resulting from each type of SU5402 treatmen
DsRed (red) in all cardiomyocyte nuclei and Amhc (green) in atrial cells, as in Fig. 1. Scale ba
treated continuously or during gastrulation occasionally exhibited severe tail truncations c
truncated embryos were excluded from quantiﬁcation of cardiomyocytes. The concentration
DY, unpublished results). (L) Quantiﬁcation of cardiomyocytes at 48 hpf after each type of SU5
indicate statistically signiﬁcant differences relative to DMSO-treated controls (pb0.005, Stu
treatment is also signiﬁcantly different from the control number, although with a larger p val
ace mutant embryos and embryos treated with SU5402. n=33 for DMSO, n=8 for continuo
n=22 for tube treatment; see also Supplemental Table 3.amhc-expressing cells do not appear to be altered in ace mutants at
this stage, the areas of vmhc and amhc expression suggest that ace
mutants have only one-third of the number of vmhc-expressing cells
and two-thirds of the number of amhc-expressing cells seen in wild-
type embryos (Fig. 2F). Together, our data reveal that the inﬂuence ofmbers. (A) Schematic depicts the transient periods of FGF signaling inhibition caused by
ng, and tan lines represent intervals of SU5402 treatment. Control embryos were treated
48 hpf, “gastrulation” treatment began at 30% epiboly and ended at the tailbud stage
pf, and “tube” treatment extended from 24 hpf to 48 hpf. (B–K) Representative 48 hpf
t, coupled with respective frontal views of hearts in which immunoﬂuorescence detects
r represents 50 μm; all images of hearts are shown at the same magniﬁcation. Embryos
haracteristic of higher SU5402 concentrations (Grifﬁn and Kimelman, 2003); severely
of SU5402 used did not induce nonspeciﬁc apoptosis, as indicated by TUNEL (SRM and
402 treatment. Graph indicates mean and standard deviation for each data set; asterisks
dent's t-test). Note that the total number of cardiomyocytes following somitogenesis
ue (pb0.01). (M) Graph indicates fold difference in mean values relative to wild-type for
us treatment, n=28 for gastrulation treatment, n=28 for somitogenesis treatment, and
401S.R. Marques et al. / Developmental Biology 321 (2008) 397–406fgf8 on both ventricular and atrial lineages begins at early stages, prior
to heart tube assembly.
FGF signaling inﬂuences both the ventricular and atrial lineages during
gastrulation stages
We wondered whether the impact of Fgf8 on cardiomyocyte
numbers could begin as early as gastrulation stages, when fgf8
transcripts accumulate in a dorsoventral gradient at the margin of the
embryo, with the highest levels of fgf8 expression positioned dorsally
(Fürthauer et al., 1997; Reifers et al., 1998). Fate maps of the zebraﬁsh
blastula indicate that myocardial progenitors reside in a region of the
lateral margin that overlaps with the fgf8 expression domain (Keegan
et al., 2004; Stainier et al., 1993). Furthermore, ventricular and atrial
progenitors are spatially organized prior to gastrulation, with
ventricular progenitors located more dorsally and atrial progenitors
located more ventrally (Keegan et al., 2004). Thus, myocardial
progenitors, particularly ventricular progenitors, are likely to be
exposed to Fgf8 during gastrulation.
To test whether FGF signaling during gastrulation is required for
production of the proper number of cardiomyocytes, we treated
embryos with 12.5 μM SU5402, a speciﬁc inhibitor of FGFR tyrosine
kinase activity (Mohammadi et al., 1997). Since the effects of SU5402
are rapid and reversible (see Materials and methods), adding and
removing the compound at different stages allowed us to create a
transient period of attenuated FGF signaling and evaluate its impact
on cardiomyocyte number at 48 hpf (Fig. 3A). We compared embryos
exposed to SU5402 continuously (from 30% epiboly to 48 hpf; Figs. 3A,
D, E) to embryos exposed only during gastrulation (from 30% epiboly
to tailbud stage; Figs. 3A, F, G). Embryos continuously exposed to
SU5402 morphologically resemble ace mutants (Fig. 3D; SRM and DY,
unpublished data): they lack the midbrain–hindbrain boundary and
exhibit a shortened body axis, consistent with roles of FGF in brain,
trunk, and tail development (Grifﬁn and Kimelman, 2003). Addition-
ally, hearts of embryos continuously exposed to SU5402 resemble ace
mutant hearts morphologically and in terms of cell number (Figs. 1B, C
and Figs. 3E, L, M; Supplemental Table 3). The hearts of embryos
treated during gastrulation appear slightly larger than the hearts of
continuously treated embryos (Figs. 3E, G), though they are still
small and dysmorphic relative to wild-type (Fig. 3C). Consistent with
their morphology, the hearts of embryos treated during gastrulation
exhibit signiﬁcant deﬁciencies in both ventricular and atrial cell
numbers (Figs. 3L, M; Supplemental Table 3). It is noteworthy that
both continuous treatment and treatment during gastrulation reduce
ventricular cell number more signiﬁcantly then atrial cell number, as
seen in ace. The same trend is seen in embryos exposed to 9 μM
SU5402 during gastrulation (Supplemental Table 4). Comparing the
effectiveness of the different SU5402 treatments, we observe similarFig. 4. Heat shock of Tg(hsp70:ca-fgfr1) embryos causes ectopic FGF signaling and perturbs p
dorsal views, anterior to the left. (A) After heat shock at 24 hpf, non-transgenic (non-tg) em
midbrain–hindbrain boundary and the pharyngeal pouches. (B) In contrast, heat shock of tran
72 hpf of embryos after heat shock at the 8-somite stage. (C) Non-transgenic embryos exhibit
as shown here (n=14/50), or have two small ﬁns (n=31/50).effects on atrial cell number in ace mutants, embryos exposed to
SU5402 continuously, and embryos exposed to SU5402 during
gastrulation (Fig. 1C and Figs. 3L, M). In contrast, ventricular cell
number appears more affected in ace mutants and in embryos
treated continuously with SU5402 than it is in embryos treated only
during gastrulation (Figs. 1C and 3L, M). Taken together, our results
indicate that FGF signaling during gastrulation stages plays an
important role in promoting the formation of both ventricular and
atrial cardiomyocytes.
A continuing inﬂuence of FGF signaling on ventricular cardiomyocyte
number
While FGF signaling during gastrulation clearly has a potent effect
on cardiomyocyte formation, our data also imply that the impact of
FGF signaling on the ventricular lineage extends beyond these stages,
since we ﬁnd that continuous treatment with SU5402 has a stronger
effect than treatment only during gastrulation on the number of
ventricular cardiomyocytes (Figs. 3L, M). The locations of myocardial
progenitors after gastrulation continue to correlate with the
locations of fgf8 expression, with particular proximity of ventricular
progenitors to sources of fgf8 (Reifers et al., 2000). Following
gastrulation, myocardial progenitors integrate into the LPM, with
ventricular progenitors located more medially than atrial progenitors
(Schoenebeck et al., 2007). Robust expression of pre-cardiac markers
like nkx2.5 begins around the 6–8-somite stage, at which time fgf8
expression is medially adjacent to and overlapping with the pre-
cardiac portion of the LPM (Reifers et al., 2000). Terminal
differentiation of cardiomyocytes begins around the 13-somite
stage, when these cells initiate expression of myocardial markers
like cmlc2 (Yelon et al., 1999). Heart tube assembly then facilitates
the merger of bilateral cardiomyocyte populations and creates
discrete domains of ventricular and atrial cardiomyocytes within
the linear tube by 24 hpf (Auman et al., 2007). Even after myocardial
differentiation is underway, fgf8 expression persists in ventricular
cells and is apparent in the ventricular portion of the heart tube
(Reifers et al., 2000). Thus, the fgf8 expression pattern suggests
multiple opportunities for FGF signaling to inﬂuence ventricular
development.
To test whether FGF signaling is required for cardiomyocyte
formation after gastrulation stages, we examined the effects of
inhibiting FGF signaling during somitogenesis stages (from the 8-
somite stage to 24 hpf; hereafter referred to as somitogenesis
treatment) and after the heart tube has formed (from 24 hpf to
48 hpf; hereafter referred to as tube treatment) (Fig. 3A). Embryos
exposed to SU5402 during somitogenesis and tube stages show
disorganized development of tail somites (Figs. 3H, J), consistent with
reported roles for FGF in posterior myogenesis (Hamade et al., 2006).ectoral ﬁn development. (A, B) In situ hybridization depicts pea3 expression at 32 hpf;
bryos show a wild-type restriction of pea3 expression to speciﬁc regions, including the
sgenic (tg) embryos causes strong and ectopic expression of pea3. (C, D) Dorsal views at
pectoral ﬁns of normal length (bar). (D) Transgenic embryos lack at least one pectoral ﬁn,
402 S.R. Marques et al. / Developmental Biology 321 (2008) 397–406Additionally, somitogenesis treatment results in tubular ventricles
with expanded atria (Fig. 3I) and causes a signiﬁcant loss of ventricular
cardiomyocytes (Figs. 3L, M; Supplemental Table 3); however, atrial
cell number is unchanged. A similar, though not statistically
signiﬁcant, trend is observed in embryos exposed to 9 μM SU5402
during somitogenesis stages (Supplemental Table 4). Tube treatment
results in mild defects in cardiac looping and chamber morphology
(Fig. 3K) and also causes a signiﬁcant reduction in ventricular cell
number (Figs. 3L, M, Supplemental Table 3); like somitogenesis
treatment, tube treatment does not affect atrial cell number. Together,
these results reveal that FGF signaling has a continuing inﬂuence on
ventricular cell number that extends well beyond its role during
gastrulation.Fig. 5. Increased FGF signaling prior to terminal differentiation induces a surplus of cardio
embryos at 48 hpf, lateral views, exhibiting morphology resulting from heat shock at the 8-s
immunoﬂuorescence detects DsRed (red) in all cardiomyocyte nuclei and Amhc (green) in a
same magniﬁcation. (C, D) Although heat shock at the 8-somite stage causes pericardial edem
Quantiﬁcation of cardiomyocytes at 48 hpf reveals that increased FGF signaling causes a signi
indicates mean and standard deviation for each data set; asterisks indicate statistically signiﬁ
n=18 for heat shock at the 8-somite stage, and n=14 for heat shock at 24 hpf; see also SupEctopic FGF signaling prior to terminal differentiation creates a
cardiomyocyte surplus
Our loss-of-function data point to a general correlation between
levels of FGF signaling and the number of cardiomyocytes generated.
Prior studies have shown that ectopic FGF signaling is sufﬁcient to
induce cardiac gene expression; for example, FGF8-soaked beads
induce nkx2.5 in chick (Alsan and Schultheiss, 2002) and zebraﬁsh
(Reifers et al., 2000). However, it is not known whether induction of
gene expression by ectopic FGF signaling results in a surplus of
cardiomyocytes. To test this hypothesis, we employed transgenic
embryos carrying Tg(hsp70:ca-fgfr1), which allows heat-inducible
expression of a constitutively active form of Fgfr1 (see Materials andmyocytes. (A–F) Representative non-transgenic (A) or Tg(hsp70:ca-fgfr1) (C, E) sibling
omite stage (C) or at 24 hpf (E), coupled with respective frontal views of hearts in which
trial cells, as in Fig. 1. Scale bar represents 50 μm; all images of hearts are shown at the
a (C) and dysmorphic cardiac chambers (D), heat shock at 24 hpf does neither (E, F). (G)
ﬁcant cardiomyocyte surplus only in embryos heat shocked at the 8-somite stage. Graph
cant differences relative to non-tg controls (pb0.005, Student's t-test). n=24 for non-tg,
plemental Table 5.
Fig. 6. Increased FGF signaling enhances formation of cardiomyocyte populations and
inhibits formation of the pectoral ﬁn ﬁeld. (A–H) In situ hybridization depicts
expression of cmlc2, vmhc, amhc and tbx5 at the 19-somite or 21-somite stage in non-
transgenic (A, C, E, G) and Tg(hsp70:ca-fgfr1) (B, D, F, H) sibling embryos after heat shock
at the 8-somite stage; dorsal views, anterior to the top. Scale bar represents 50 μm; all
images are shown at the same magniﬁcation. (A, B) Ectopic FGF signaling leads to a
posterior expansion of cmlc2-expressing cardiomyocytes (n=30/37). (C, D) Ectopic FGF
signaling leads to a posterior expansion of vmhc-expressing ventricular cardiomyocytes
(n=16/19). (E, F) Ectopic FGF signaling leads to a mild posterior expansion of amhc-
expressing atrial cardiomyocytes (n=8/10). (G, H) Ectopic FGF signaling leads to
reduction of the pectoral ﬁn ﬁeld, as demarcated by tbx5 expression (n=18/18).
403S.R. Marques et al. / Developmental Biology 321 (2008) 397–406methods). Heat shock of transgenic embryos rapidly induces high
levels of FGF signaling throughout the embryo: ectopic and robust
expression of the FGF pathway target gene pea3 begins as early as 2 h
after heat shock and is maintained for at least 8 h (Figs. 4A, B; SRM, YL,
KDP, and DY, unpublished data).
We increased FGF signaling through heat shock of transgenic
embryos at the beginning of each time interval analyzed with SU5402
treatment. First, we found that heat shock of transgenic embryos at
30% epiboly results in severely dorsalized embryos consistent with
what has been previously reported for fgf8 RNA injection (Fürthauer et
al., 1997), preventing us from analyzing ventricular and atrial cell
numbers at 48 hpf (SRM, YL, KDP, and DY, unpublished data). In
contrast, heat shock of transgenic embryos at the 8-somite stage does
not grossly disrupt embryonic axis formation (Figs. 5A, C), although it
does cause body elongation (Fig. 5C), yolk extension abnormalities
(Fig. 5C), and pectoral ﬁn (forelimb) defects ranging from loss of ﬁns to
reduction of ﬁn size (Figs. 4C, D). Heat shock at the 8-somite stage also
results in severe pericardial edema (Fig. 5C) and elongated cardiac
chambers (Figs. 5B, D). By counting ventricular and atrial cardiomyo-
cytes at 48 hpf, we found that activation of FGF signaling at the 8-
somite stage can lead to an approximately 25% increase in the
numbers of both ventricular and atrial cells (Fig. 5G; Supplemental
Table 5).
The cardiomyocyte surplus caused by heat shock at the 8-somite
stage is evident even a few hours following overexpression of the
constitutively active receptor: heat shocked embryos exhibit posterior
expansions of cmlc2, vmhc, and amhc expression within the LPM prior
to heart tube assembly (Figs. 6A–F). Based on the observed expansion,
it is interesting to consider that increased FGF signaling may recruit
cells into the myocardial lineage from positions posterior to the heart
ﬁeld. Coincident with the appearance of enlarged heart ﬁelds in
embryos heat shocked at the 8-somite stage, we also observe
reduction of the pectoral ﬁn ﬁelds, bilateral zones of tbx5 expression
located posterior to the heart ﬁelds within the LPM (Figs. 6G, H) (Ahn
et al., 2002; Begemann and Ingham, 2000). This loss of pectoral ﬁn
precursors is consistent with the observed reduction or absence of
pectoral ﬁns at later stages (Figs. 4C, D) and suggests the possibility
that ectopic FGF signaling can transform pectoral ﬁn progenitors into
myocardial progenitors.
Loss of FGF signaling does not enlarge the pectoral ﬁn ﬁeld
The notion that ectopic FGF signaling may recruit cells from the
forelimb ﬁeld into the heart ﬁeld suggests that endogenous FGF
signaling might play a role in distinguishing the developmental
potential of the heart and forelimb ﬁelds. In this scenario, loss of FGF
signaling would cause expansion of the forelimb ﬁeld at the expense
of the heart ﬁeld. However, ace mutants develop normal pectoral ﬁns
(Reifers et al., 1998), and fgf24mutants display normal tbx5 expression
(Fischer et al., 2003) at 24 hpf. It has also been reported that exposure
to SU5402 from the 1-somite stage until the 23-somite stage does not
perturb tbx5 expression (Mercader et al., 2006). However, prior
studies have not addressed whether loss of FGF signaling during
gastrulation stages could result in pectoral ﬁn ﬁeld expansion.
We examined tbx5 expression in the forelimb ﬁelds and in the
pectoral ﬁns of embryos treated with SU5402 continuously, during
gastrulation, or during somitogenesis (Fig. 7). None of these
treatments causes expansion of the area of tbx5 expression in the
pectoral ﬁn ﬁeld at 20 hpf (Figs. 7A, C, E, G). Pectoral ﬁn size at 48 hpf
also appears normal in embryos treated with SU5402 during
gastrulation (Fig. 7F) or somitogenesis (Fig. 7H), although ﬁn
morphology appears variably aberrant following somitogenesis treat-
ment. Embryos continuously treated with SU5402 lack pectoral ﬁns at
48 hpf (Fig. 7D), consistent with a role for Fgf24 in pectoral ﬁn
development after 24 hpf (Fischer et al., 2003; Mercader et al., 2006).
Thus, while loss of FGF signaling results in a reduction of the heartﬁeld, we cannot detect a concomitant expansion of the forelimb ﬁeld.
Taken together, these results do not support a role for FGF signaling in
regulating a decision between heart and forelimb fates.
Induction of ectopic FGF signaling after heart tube assembly does not
affect cardiomyocyte number
Generation of a cardiomyocyte surplus by ectopic FGF signaling
suggests that some developmental plasticity remains within the organ
ﬁelds of the LPM during somitogenesis stages. We wondered whether
this plasticity is maintained after myocardial differentiation begins. To
address this, we chose to induce ectopic FGF signaling via heat shock
of Tg(hsp70:ca-fgfr1) embryos at 24 hpf. Like heat shock at the 8-
somite stage, heat shock of transgenic embryos at 24 hpf does not
disturb general embryonic morphology (Fig. 5E). However, in contrast
Fig. 7. Reduction of FGF signaling does not expand the forelimb ﬁeld. (A–H) In situ
hybridization depicts expression of tbx5 at 20 hpf (A, C, E, G) and 48 hpf (B, D, F, H);
dorsal views, anterior to the top. Scale bar represents 50 μm; all images are shown at the
same magniﬁcation. (A–D) Compared to control embryos treated only with DMSO
(A, B), embryos exposed to continuous SU5402 treatment exhibit normal areas of tbx5
expression in the pectoral ﬁn ﬁelds at 20 hpf (C; n=8/8) but lack pectoral ﬁns at 48 hpf
(D; n=15/15). (E, F) Embryos treated with SU5402 during gastrulation exhibit normal
areas of tbx5 expression in the pectoral ﬁn ﬁelds at 20 hpf (n=16/16) and normal
pectoral ﬁns at 48 hpf (n=18/18). (G, H) Embryos treated with SU5402 during
somitogenesis do not display increased areas of tbx5 expression in the pectoral ﬁn ﬁelds
at 20 hpf (n=9/9) and do not have detectable defects in pectoral ﬁn size at 48 hpf (n=15/
16), although ﬁn morphology varies between treated embryos. It is noteworthy that the
level of tbx5 expression generally appears higher inwild-type embryos than in SU5402-
treated embryos.
Fig. 8. FGF signaling plays reiterative roles in the establishment of heart size and
chamber proportionality in zebraﬁsh. (A–F) Schematics depict a model for the roles of
FGF signaling indicated by our data. Each image represents the quantities of ventricular
(red) or atrial (yellow) progenitor cells or cardiomyocytes and the locations of Fgf8
activity at the 30% epiboly stage (A, B, lateral views), the 8-somite stage (C, D, dorsal
views), and 24 hpf (E, F, dorsal views), either in wild-type embryos (A, C, E) or in
embryos with reduced FGF signaling (B, D, F). Locations of ventricular and atrial cells
and Fgf8 activity inwild-type embryos are based on established fate map data and gene
expression patterns (Auman et al., 2007; Fürthauer et al., 1997; Keegan et al., 2004;
Reifers et al., 1998; Reifers et al., 2000; Schoenebeck et al., 2007). Differences depicted in
(B, D, F) are inferred from the results presented here. (A, B) During gastrulation, FGF
signaling along the margin inﬂuences both heart size and chamber proportionality by
promoting speciﬁcation or proliferation of myocardial progenitors, particularly
ventricular progenitors. (C, D) During somitogenesis, FGF signaling near the medial
LPM continues to inﬂuence ventricle proportion by promoting maintenance, prolifera-
tion, or differentiation of ventricular progenitors. (E, F) In the ventricular portion of the
heart tube, FGF signaling inﬂuences ventricle proportion by regulating maintenance or
augmentation of the ventricular cardiomyocyte population.
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formation appears to progress normally after heat shock at 24 hpf
(SRM and DY, unpublished data). In an additional contrast to heat
shock at the 8-somite stage, heat shock at 24 hpf only subtly affects
heart morphology and looping (Figs. 5B, F) and does not affect
ventricular or atrial cell number (Fig. 5G; Supplemental Table 5). Thus,
our data suggest that, although ectopic FGF signaling at early stages
can generate enlarged cardiomyocyte populations, this responsive-
ness to heightened FGF signaling is lost after the onset of myocardial
differentiation.
Discussion
Our data demonstrate that FGF signaling plays an essential part in
establishing the proper numbers and types of cardiomyocytes througha series of roles, beginningwhenmyocardial progenitor speciﬁcation is
underwayand continuing after the heart tube has formed. First, during
gastrulation, FGF signaling promotes the formation of both ventricular
and atrial lineages (Figs. 8A, B). Although atrial cell number does not
depend on FGF signaling once gastrulation is complete, FGF signaling
continues to promote development of the ventricular lineage while
myocardial progenitor cells reside within the LPM (Figs. 8C, D). Even
after the initiation of myocardial differentiation and the assembly of
the heart tube, FGF signaling is important for the formation of the
proper number of ventricular cardiomyocytes (Figs. 8E, F). Thus,
reiterative roles of the FGF signaling pathway contribute to the
regulation of both overall heart size and chamber proportionality.
Each of the temporally distinct roles of FGF signaling during
establishment of cardiomyocyte populations correlates with the
dynamic expression pattern of fgf8, in the sense that high levels of
fgf8 expression are located near the lineages affected by a loss of
FGF signaling (Fig. 8). Moreover, given the similarities between the
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treated with SU5402, it seems likely that Fgf8 is the major FGF family
member with an inﬂuence on heart size and chamber proportionality
in zebraﬁsh.We cannot rule out the contribution of other FGFs, such as
fgf3 and fgf24, which are coexpressed with fgf8 during gastrulation
(Fürthauer et al., 2004); however, neither the fgf3 nor fgf24 mutant
phenotypes are known to include cardiac defects (Fischer et al., 2003;
Herzog et al., 2004). Hereafter, for simplicity of discussion, we refer to
Fgf8 as the primary ligand of interest.
The temporally distinct effects of Fgf8 signaling on cardiomyocyte
numbers provide suggestions for the cellular mechanisms responsible
for establishing heart size and chamber proportionality. The early
impact of Fgf8 signaling on heart size likely reﬂects a role of Fgf8
during the initial speciﬁcation of ventricular and atrial myocardial
progenitors or during the proliferation of these progenitors. During
gastrulation stages, the multipotential mesendodermal progenitor
cells that will ultimately give rise to the ventricular or atrial lineages
are thought to be in the process of integrating the inductive signals
that regulate their fate assignment (Brand, 2003; Zaffran and Frasch,
2002). Although our data do not address the cell autonomy of the
requirement for receiving Fgf8 signaling, the known proximity of fgf8
expression to the origins of myocardial progenitors indicates an
opportunity for inductive signal reception by progenitor cells. There-
fore, we propose that Fgf8 signaling helps to establish heart size in
zebraﬁsh by promoting the formation of a properly sized myocardial
progenitor pool, consistent with the roles of FGF signaling during
cardiac speciﬁcation in Drosophila and Ciona (Davidson et al., 2006;
Michelson et al., 1998).
Similar to its inﬂuence on heart size, the impact of Fgf8 signaling
on chamber proportionality begins during gastrulation. The ventri-
cular lineage is more sensitive than the atrial lineage to reduction of
Fgf8 signaling during gastrulation, and the sensitivity of ventricular
cells continues during somitogenesis and tube assembly, well beyond
the sensitivity of the atrial population. The reiterative importance of
Fgf8 signaling for establishment of ventricular cardiomyocyte num-
bers is consistent with the previously reported suggestion of a
continuous requirement for Fgf8 signaling during zebraﬁsh heart
development (Reifers et al., 2000). Our data conﬁrm and extend this
prior work, providing a quantitative assessment of both ventricular
and atrial cell number phenotypes in loss-of-function and gain-of-
function scenarios at multiple stages.
Do the reiterative roles of FGF signaling in the establishment of
chamber proportionality, like the role of FGF signaling in establishing
heart size, reﬂect regulation of progenitor speciﬁcation? During
gastrulation and somitogenesis stages, the proximity of ventricular
progenitors to the highest levels of fgf8 expression (Figs. 8A, C)
suggests an appealing model in which Fgf8 controls a ventricular/
atrial fate decision: higher levels of Fgf8 signaling could induce
ventricular identity, whereas lower levels of signaling could induce
atrial identity. However, neither gastrulation treatment nor somito-
genesis treatment with SU5402 leads to enhanced numbers of atrial
cells, as would be expected if reduced Fgf8 signaling favored atrial
speciﬁcation over ventricular speciﬁcation. Additionally, ectopic FGF
signaling at the 8-somite stage leads to increases in both ventricular
and atrial populations, instead of increasing the ventricular popula-
tion at the expense of the atrial population. Therefore, although Fgf8
signaling may promote ventricular speciﬁcation, particularly at
gastrulation stages, its impact on chamber proportionality is more
consistent with a particular inﬂuence on the ventricular lineage than
with a role in regulating a binary decision between ventricular and
atrial identities.
The comparison of FGF pathway loss-of-function and gain-of-
function phenotypes during somitogenesis provides additional ideas
for cellular mechanisms regulating ventricle proportion. Rather than
reﬂecting a role in ventricular progenitor speciﬁcation, the functions
of Fgf8 signaling at these stages may indicate its importance formaintaining a population of ventricular progenitors, or for regulating
the differentiation or proliferation of this population. These explana-
tions ﬁt well with the location of fgf8 expression medially adjacent to
the ventricular progenitor population (Fig. 8C). However, the ability of
ectopic FGF signaling at the 8-somite stage to increase both the atrial
and ventricular cardiomyocyte populations indicates an effect that
extends beyond nurturing a population of ventricular progenitors.
This expansion of both atrial and ventricular cells suggests that a
degree of plasticity is retained in the LPM even after the initiation of
nkx2.5 expression, such that cell identity can still be swayed by high
levels of FGF signaling.
Like reduction of Fgf8 signaling during somitogenesis, reduction of
Fgf8 signaling after heart tube assembly results in a signiﬁcant
decrease in ventricular cell number but has no effect on atrial cell
number. This is not likely to reﬂect a role of FGF signaling in promoting
ventricular progenitor speciﬁcation, since ectopic FGF signaling at
24 hpf is unable to increase the number of cardiomyocytes.
Additionally, although cardiomyocyte proliferation would be an
attractive mechanism for ventricular growth, the failure of ectopic
FGF signaling to enhance cardiomyocyte cell number argues against
its regulation of ventricular proliferation. Furthermore, we have
detected very few proliferating cells with BrdU incorporation assays
or with phospho-histone-3 immunohistochemistry in either wild-
type or SU5402-treated cardiomyocytes between 24 and 48 hpf (SRM
and DY, unpublished data). This is consistent with prior studies
showing that, even though the number of cardiomyocytes increases
by as much as 50% between 24 and 36 hpf (Rohr et al., 2006; Sato et al.,
2006; Shu et al., 2003), the cardiomyocyte mitotic index is no greater
than 10% during this time period (Rohr et al., 2006).
Instead of suggesting a late role of Fgf8 in ventricular speciﬁcation
or proliferation, our results point toward a role of Fgf8 in maintaining
the proper number of differentiated ventricular cardiomyocytes,
perhaps by promoting ventricular cardiomyocyte survival. However,
TUNEL analysis of embryos treated with SU5402 during tube stages
did not reveal an increase in apoptotic cardiomyocytes, and the
ventricular cell number deﬁciency in ace mutant embryos is not
ameliorated by treatment with caspase antagonists at tube stages
(SRM and DY, unpublished data). Therefore, rather than invoking a
role for Fgf8 in ventricular cardiomyocyte survival, it is interesting to
consider another possibility, in which Fgf8 plays a role in the
recruitment of additional cardiomyocytes into the heart tube after
24 hpf. Consistent with this model, tissue-speciﬁc Fgf8 knockout mice
have implicated Fgf8 in the regulation of proliferation and survival of
progenitor cells within the anterior heart ﬁeld, which contributes
cardiomyocytes to the outﬂow pole after the formation of the
primitive heart tube (Ilagan et al., 2006; Park et al., 2006). Perhaps
Fgf8 signaling regulates the addition of cells from a secondary source
to the outﬂow pole of the zebraﬁsh heart, potentially by promoting
their survival, differentiation, or migration. This secondary source
could be the zebraﬁsh equivalent to the amniote anterior heart ﬁeld or,
alternatively, might relate to the neural crest populations that have
been suggested to contribute to the zebraﬁsh myocardium (Li et al.,
2003; Sato et al., 2006; Sato and Yost, 2003).
Taken together, our data suggest a model in which a single
signaling pathway, and perhaps even a single growth factor, can act
reiteratively to coordinate heart size and chamber proportionality.
Fgf8 signaling acts early to create a cardiac progenitor pool of
appropriate total size and ventricular/atrial proportionality. However,
ventricle proportion is not regulated solely through generation of
progenitor cells; it is also enforced by the continuing chamber-speciﬁc
effects of Fgf8 that impact ventricular progenitor maintenance,
ventricular differentiation, or recruitment of additional ventricular
cardiomyocytes. The effects of FGF signaling extend even further into
the more mature ventricle, in which FGFs inﬂuence ventricular
growth, homeostasis, and regeneration (Lavine et al., 2005; Lepilina
et al., 2006;Wills et al., 2008). In future studies, it will be important to
406 S.R. Marques et al. / Developmental Biology 321 (2008) 397–406determine whether the same downstream effectors of FGF signaling
are utilized in each temporal context and to elucidate how the FGF
pathway networks with other pathways that contribute to myocardial
speciﬁcation, differentiation, and maintenance during the establish-
ment of heart size and chamber proportionality.
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